- Saleh, Radhwan A.A.
- Álvarez-Rodríguez, Lorena
- Cordón Ciordia, Beatriz
- García-Martín, Elena
- Aptoula, Erchan
- Moura, Joaquim de
Presented at: 2026 International Joint Conference on Neural Networks (IJCNN), 22-26 June 2026, Maastricht, Netherlands
© 2026 IEEE. This version of the article has been accepted for publication, after peer review. Personal use of this material is permitted. Permission from IEEE must be obtained for all other uses, in any current or future media, including reprinting/republishing this material for advertising or promotional purposes, creating new collective works, for resale or redistribution to servers or lists, or reuse of any copyrighted component of this work in other works. The Version of Record is available online at: https://doi.org/10.1109/IJCNN69854.2026.11728446, [Abstract] The COVID-19 pandemic has underscored the systemic impact of the virus, including retinal abnormalities that may affect vision. Precise segmentation of retinal layers in optical coherence tomography (OCT) images is essential for reliable diagnosis and monitoring. We present the Hierarchical Multi-Scale Axial Attention Network (HMSANet), a novel deep learning architecture specifically designed for retinal layer segmentation in COVID-19 OCT data. HMSANet integrates two main modules: the Multi-Path Inception Attention Module (MPIAM) for multi-scale feature extraction, and the Multi-Scale Attention Module (MSAM) for adaptive attention weighting across spatial scales. This design enables the model to capture both fine-grained and large-scale retinal changes associated with COVID-19. Experimental results show that HMSANet consistently outperforms U-Net and SCAttNet by at least 1.2% in several retinal layers, demonstrating improved sensitivity to subtle structural alterations. By automating retinal layer segmentation, HMSANet enhances diagnostic speed and consistency, with potential applicability to other retinal diseases., This study was supported by the Carlos III Health Institute through grants PI23/00935 and RD21/0002/0050 (Inflammatory Disease Network– RICORS), and by the Government of Aragon through group B23 23R. It also received funding from the Ministerio de Ciencia e Innovación (PID2023148913OB-I00) and from the Consellería de Educación, Universidade e Formación Profesional, Xunta de Galicia, under the Grupos de Referencia Competitiva program (ED431C 2024/33). Additional support was provided by the Carlos III Health Institute through grant FORT23/00010 (FORTALECE Program), the European Union via the 3i ICT project (H2020-MSCA-COFUND-2020, grant agreement GA 101034261), and the Consellería de Cultura, Educación, Formación Profesional e Universidades of the Xunta de Galicia through the 3i ICT COFUND agreement. Consellería de Educación, Ciencia, Universidades e Formación Profesional (Xunta de Galicia- Convenio para o desenvolvemento de accións estratéxicas de I+D+i 20252026)., Xunta de Galicia; ED431C 2024/33